Check your fridge! Salads, salsas recalled for salmonella concerns sold in Vermont.
The Food and Drug Administration published a recall announcement saying that 17 products were made with cucumbers grown by Bedner Growers, Inc., who recently recalled some of their cucumbers due to salmonella contamination. Out of a similar concern, these products were recalled.
"Consumers, restaurants, retailers, and wholesalers should not eat, sell, or serve the recalled products containing those cucumbers," the administration said.
The affected items were distributed to stores between May 6, 2025, and May 21, 2025, to multiple customers in Delaware, Maryland, Massachusetts, Michigan, New Jersey, North Carolina, Ohio, Pennsylvania, Vermont, Virginia, Washington D.C., and West Virginia.
Here are the salad and salsa products recalled in Vermont.
Here are the recalled salad products, according to the Food and Drug administration.
UPC
PACK/SZ
BRAND
DESCRIPTION
ALL LOT CODES
766375251385
1/8 OZ
Jack and Olive
The House Salad
All Lot Codes
766375241973
1/8 OZ
Created Fresh
The House Salad
All Lot Codes
766375737018
1/8 OZ
Spring and Sprout
The House Salad
All Lot Codes
766375241607
1/5.2 OZ
Created Fresh
Mini Garden Salad
All Lot Codes
766375261681
1/5.76 OZ
Created Fresh
Chicken Salad on Everything Fecelle
All Lot Codes
766375261698
1/5.76 OZ
Created Fresh
Egg Salad on Everything Fecelle
All Lot Codes
766375261674
1/5.76 OZ
Created Fresh
Tuna Salad on Everything Fecelle
All Lot Codes
766375253044
1/11.25 OZ
Created Fresh
Southwestern Breakfast Bowl
All Lot Codes
One of the recalled products is not technically a salad, but instead a breakfast bowl.
Here are the recalled salsa products, according to the Food and Drug administration.
UPC
PACK/SZ
BRAND
DESCRIPTION
ALL LOT CODES
640344010282
1/16 OZ
East Coast Fresh
Fresh Mild Salsa
All Lot Codes
640344012781
1/16 OZ
East Coast Fresh
Fresh Mild Salsa
All Lot Codes
070784034140
1/16 OZ
TOPS
Salsa HOT TOPS (E)
All Lot Codes
070784033846
1/16 OZ
TOPS
Fresh Salsa 1lb CUP
All Lot Codes
888670065808
1/30 OZ
Wellsley Farms
Wellsley Farms Mild Salsa
All Lot Codes
041497075959
1/16 OZ
WEIS
Salsa Mild WEIS
All Lot Codes
688267031953
1/16 OZ
AHOLD
Salsa HOT AHOLD
All Lot Codes
688267032523
1/16 OZ
AHOLD
Salsa 1#-AHOLD
All Lot Codes
640344069624
1/16 OZ
East Coast Fresh
SALSA RETAIL 1# CUP
All Lot Codes
According to the FDA, illness usually occurs within 12 to 72 hours after eating food that is contaminated with salmonella, and the symptoms usually last four to seven days. Symptoms include diarrhea, fever, and abdominal cramps.
Children younger than five, the elderly, and people with weakened immune systems are more likely to have severe infections, the FDA says.
Contact your healthcare provider immediately if you think you may have symptoms of a salmonella infection.
Gabe Hauari and Mary Walrath-Holdridge contributed to the reporting of this story.
Rin Velasco is a trending reporter. She can be reached at rvelasco@gannett.com.
This article originally appeared on Burlington Free Press: FDA says some salads, salsas recalled for salmonella concerns in VT
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Washington Post
15 minutes ago
- Washington Post
How much sugar is in orange juice? Here's what to know.
The Food and Drug Administration on Tuesday proposed a tweak to reduce the amount of sugar required in pasteurized orange juice. But the news from the Trump administration isn't a proposal to lower the amount of sugar in the American diet; it's intended to help Florida's citrus industry because the sugar content of Florida oranges has been steadily dropping due to a bacterial disease afflicting the crop.
Yahoo
2 hours ago
- Yahoo
Medical device industry says future MDUFA hikes unsustainable
This story was originally published on MedTech Dive. To receive daily news and insights, subscribe to our free daily MedTech Dive newsletter. Medical device companies advocated against future increases to user fees at a public hearing Monday for the next medical device user fee amendments. Meanwhile, Food and Drug Administration leaders, facing congressional budget cuts, made a case for more user fees, emphasizing the importance of the program. The five-year agreement determines the amount the FDA can raise from the medtech industry to supplement congressional appropriations. In the current MDUFA program, which ends in September 2027, the FDA's device center negotiated a boost in user fee funding in exchange for meeting certain review timelines and staffing levels. The next agreement would take effect in October 2027 and run through 2032. Michelle Tarver, director of the FDA's Center for Devices and Radiological Health, said the FDA 'requires sustained and increased investment by the medical device industry' to meet its goals. The device leader added that 'holding steady does not lead to excellence — it leads to mediocrity.' However, device industry lobbyists at the meeting indicated a preference for few changes. 'Each MDUFA cycle included significant resources and investments, including increasing the number of [full-time employees] to support the program,' said Janet Trunzo, senior executive vice president of technology and regulatory affairs for AdvaMed. 'Now that we have approached nearly 25 years … of user fee programs for medical devices, we are now in a position of merely fine-tuning the current program.' Mark Leahey, CEO of the Medical Device Manufacturers Association, called for the process to return 'back to the basics' in comments on Monday. Leahey said the funds from MDUFA should go to reviewers and medical officers, and added that the industry wants more visibility as to where the funds are going and 'where people are right now, realizing there's been some attrition over the last six months.' Citing the latest user fee rates, Leahey said more than $427 million in fees were authorized for fiscal year 2026. 'We have to realize the size and scope of the investments here,' he said. 'And this is not a sustainable pathway.' The meeting kicked off a process where the FDA will seek public comment through Sept. 4, before beginning negotiations with industry. When a final agreement is reached, the FDA will present it to Congress, which must approve the next MDUFA program. The negotiations come during a period of uncertainty, where several leaders have left the FDA under Health and Human Services Secretary Robert F. Kennedy Jr. The Trump administration's slashing of probationary FDA employees in February — followed by rehiring some staffers, and then more firings in April — raised questions about whether the FDA's user fees programs could be at risk. FDA Commissioner Marty Makary has suggested lowering user fees for prescription drugs; however, he has not indicated any major changes to medical device fees, referring to MDUFA as 'the best of all the user fee arrangements' during the meeting. Patient advocates call for more fees, transparency While industry pushed back against further fee increases, patient groups called for more fees to offset federal budget cuts to the FDA. Diana Zuckerman, president of the National Center for Health Research, said that given recent cuts in FDA staffing and the importance of speedy device reviews, 'it's inevitable that improving quality requires increasing the fees.' Zuckerman said that while she would like to see Congress provide enough appropriations for the FDA's device center, 'we want to make sure that there's funding for everything that's needed, and, unfortunately, appropriations isn't making that possible.' Zuckerman also called for user fees to be used for postmarket device safety, as well as for more transparency during the negotiation process, positions that were supported by other patient advocates during the meeting. In the past, user fee negotiations have been behind closed doors, and patients, consumers and health professionals have not been able to join or observe the meetings, Zuckerman said. In the last round of negotiations, the FDA also faced scrutiny for not publishing meeting minutes from its conversations with industry in a timely fashion. 'At the very least, we should have access to remotely watch those negotiations, instead of just depending on minutes that are often vague or very delayed so that stakeholders have no opportunity for meaningful input,' said Tess Robertson-Neel, on behalf of the Patient, Consumer, & Public Health Coalition, a group of more than two dozen nonprofits. Robertson-Neel added that user fees should be increased, and the FDA should focus on being 'more patient-centered and transparent and less cozy with industry.' Alexander Naum, policy manager for Generation Patient, a nonprofit representing young adults living with chronic medical conditions, said that user fees must increase and the next MDUFA agreement should include clear postmarket device safety performance goals. He also asked for the FDA to commit funds to expanding its program for tracking medical device adverse events. Naum cited a statistic that the FDA receives more than 2 million reports annually of suspected device malfunctions, serious injuries or deaths. 'So many of us rely on medical devices for our survival,' Naum said. 'Many of these devices present the potential of unexpected adverse events.' Recommended Reading FDA schedules first public MDUFA VI meeting ahead of negotiations Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Chicago Tribune
4 hours ago
- Chicago Tribune
Raw milk sickens 21 people in Florida including 6 children
TALLAHASSEE, Fla. — Six children are among 21 people who have E. coli or campylobacter infections after consuming raw milk from a farm in Florida, public health officials said. Seven people have been hospitalized, and at least two of them are suffering severe complications, the Florida Department of Health said Monday. It did not specify if any of the six infected children under 10 are among those being treated in hospitals, nor how many people were infected by E. coli, campylobacter or both bacteria. 'Sanitation practices in this farm are of particular concern due to the number of cases,' reads the state advisory, which did not identify the farm linked to the cluster of infections in northeast and central Florida. Raw milk appears to be gaining in popularity, despite years of warnings about the health risks of drinking unpasteurized products. The Food and Drug Administration and the Centers for Disease Control and Prevention say raw milk is one of the 'riskiest' foods people can consume. Raw milk is far more likely than pasteurized milk to cause illnesses and hospitalizations because of dangerous bacteria such as campylobacter, listeria, salmonella and E. coli, research shows. The infections can cause gastrointestinal illness, and in some cases may lead to serious complications, including a life-threatening form of kidney failure. Young children, the elderly, immunocompromised people and pregnant women are at greater risk of complications. 'We invented pasteurization for a reason,' said Keith Schneider, a food safety professor at the University of Florida. 'It's maddening that this is happening.' States have widely varying regulations regarding raw milk, with some allowing retail purchases in stores and others allowing sale only at farms. Some states allow 'cowshares,' in which customers buy milk produced by designated animals, and some allow consumption only by farm owners, employees or 'non-paying guests.' In Florida, the sale and distribution of raw milk for human consumption is illegal, but retailers get around the ban by labeling their products as for pet or animal food only. Schneider called it a 'wink, wink, nudge, nudge,' form of regulation. 'Everybody knows that they're selling it for human consumption,' Schneider said, adding that people getting sick — or even seriously ill — from drinking raw milk is 'not a question of if, but when.'
